A Randomised, Open, Phase I Study in Patients With Type 2 Diabetes Mellitus Treated With Metformin to Evaluate the Effect of AZD1656 on the Pharmacokinetics of Sitagliptin and Vice Versa.
Phase of Trial: Phase I
Latest Information Update: 27 May 2010
At a glance
- Drugs AZD 1656; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 27 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 Apr 2010 New trial record